Paper8519652
Carboplatin- and cisplatin-induced potentiation of moderate-dose radiation cytotoxicity in human lung cancer cell lines.
Groen HJ and 6 others. Br J Cancer, 1995. Cited by 31 papers, by iCite.
Cite this record
ConductScience Library. Carboplatin- and cisplatin-induced potentiation of moderate-dose radiation cytotoxicity in human lung cancer cell lines. Papers, record 8519652. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8519652
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Carboplatin- and cisplatin-induced potentiation of moderate-dose radiation cytotoxicity in human lung cancer cell lines.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Carboplatin | Major topic |
| Carcinoma, Small Cell | Major topic |
| Cisplatin | Major topic |
| Lung Neoplasms | Major topic |
| Cell Survival | |
| Combined Modality Therapy | |
| DNA Damage | |
| DNA, Neoplasm | |
| Dose-Response Relationship, Radiation | |
| Drug Synergism | |
| Electrophoresis | |
| Humans | |
| Nucleic Acid Conformation | |
| Radiation Tolerance | |
| Tumor Cells, Cultured |
Source PubMed
References32
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 3802100 | Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. | Cancer Res | 1987 | https://conductscience.org/library/papers/3802100 | PubMed |
| 2 | 7999772 | HMG domain proteins induce sharp bends in cisplatin-modified DNA. | Biochemistry | 1994 | https://conductscience.org/library/papers/7999772 | PubMed |
| 3 | 3549645 | Combined treatment of radiation and cisdiamminedichloroplatinum (II): a review of experimental and clinical data. | Int J Radiat Oncol Biol Phys | 1987 | https://conductscience.org/library/papers/3549645 | PubMed |
| 4 | 3562793 | Irradiation damage in chromatin isolated from V-79 Chinese hamster lung fibroblasts. | Radiat Res | 1987 | https://conductscience.org/library/papers/3562793 | PubMed |
| 5 | 3303163 | Radiosensitization in vitro by cis-diammine (1,1-cyclobutanedicarboxylato) platinum(II) (carboplatin, JM8) and ethylenediammine-malonatoplatinum(II) (JM40). | Radiother Oncol | 1987 | https://conductscience.org/library/papers/3303163 | PubMed |
| 6 | 2846161 | Characterization of a human small cell lung carcinoma cell line with acquired resistance to cis-diamminedichloroplatinum(II) in vitro. | Cancer Res | 1988 | https://conductscience.org/library/papers/2846161 | PubMed |
| 7 | 2545337 | Resistance mechanisms in three human small cell lung cancer cell lines established from one patient during clinical follow-up. | Cancer Res | 1989 | https://conductscience.org/library/papers/2545337 | PubMed |
| 8 | 2756105 | Inactivation of hypoxic cells by cisplatin and radiation at clinically relevant doses. | Radiat Res | 1989 | https://conductscience.org/library/papers/2756105 | PubMed |
| 9 | 2669136 | Biologic and clinical developments of cisplatin combined with radiation: concepts, utility, projections for new trials, and the emergence of carboplatin. | Semin Oncol | 1989 | https://conductscience.org/library/papers/2669136 | PubMed |
| 10 | 2571657 | CHEF electrophoresis, a sensitive technique for the determination of DNA double-strand breaks. | Int J Radiat Biol | 1989 | https://conductscience.org/library/papers/2571657 | PubMed |
| 11 | 1967296 | In CHEF electrophoresis a linear induction of dsb corresponds to a nonlinear fraction of extracted DNA with dose. | Int J Radiat Biol | 1990 | https://conductscience.org/library/papers/1967296 | PubMed |
| 12 | 2302704 | Use of the tetrazolium assay in measuring the response of human tumor cells to ionizing radiation. | Cancer Res | 1990 | https://conductscience.org/library/papers/2302704 | PubMed |
| 13 | 422420 | Exploitable mechanisms in combined radiotherapy-chemotherapy: the concept of additivity. | Int J Radiat Oncol Biol Phys | 1979 | https://conductscience.org/library/papers/422420 | PubMed |
| 14 | 575122 | Radiosensitization of hypoxic tumor cells by cis- and trans-dichlorodiammineplatinum (II). | Int J Radiat Oncol Biol Phys | 1979 | https://conductscience.org/library/papers/575122 | PubMed |
| 15 | 7275727 | Inherent cellular radiosensitivity as a basic concept for human tumor radiotherapy. | Int J Radiat Oncol Biol Phys | 1981 | https://conductscience.org/library/papers/7275727 | PubMed |
| 16 | 7198110 | Effect of cis-dichlorodiammine platinum II and X rays on mammalian cell survival. | Int J Radiat Oncol Biol Phys | 1981 | https://conductscience.org/library/papers/7198110 | PubMed |
| 17 | 7041539 | Criteria for analyzing interactions between biologically active agents. | Adv Cancer Res | 1981 | https://conductscience.org/library/papers/7041539 | PubMed |
| 18 | 3910216 | Carboplatin as a potentiator of radiation therapy. | Cancer Treat Rev | 1985 | https://conductscience.org/library/papers/3910216 | PubMed |
| 19 | 3704188 | Temporal interactions in the Lewis lung tumour between cytotoxic drugs and acute or fractionated radiotherapy. | Radiother Oncol | 1986 | https://conductscience.org/library/papers/3704188 | PubMed |
| 20 | 3737877 | Nuclear matrix proteins are crosslinked to transcriptionally active gene sequences by ionizing radiation. | Radiat Res | 1986 | https://conductscience.org/library/papers/3737877 | PubMed |
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 31 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41854291 | Cell-cycle-specific lesion evolution rather than inhibition of double-strand-break repair underpins cisplatin radiosensitization. | Mol Oncol | 2026 | https://conductscience.org/library/papers/41854291 | PubMed |
| 38003688 | Composition of Conditioned Media from Radioresistant and Chemoresistant Cancer Cells Reveals miRNA and Other Secretory Factors Implicated in the Development of Resistance. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/38003688 | PubMed |
| 32218101 | Role of concurrent chemoradiation on locally advanced unresectable adenoid cystic carcinoma. | Korean J Intern Med | 2021 | https://conductscience.org/library/papers/32218101 | PubMed |
| 28451402 | Efficacy and safety of antitumor agents plus radiotherapy compared with radiotherapy alone for brain metastases from lung cancer. | Mol Clin Oncol | 2017 | https://conductscience.org/library/papers/28451402 | PubMed |
| 26991853 | DNA damage response (DDR) pathway engagement in cisplatin radiosensitization of non-small cell lung cancer. | DNA Repair (Amst) | 2016 | https://conductscience.org/library/papers/26991853 | PubMed |
| 24817947 | DNA microarray reveals ZNF195 and SBF1 are potential biomarkers for gemcitabine sensitivity in head and neck squamous cell carcinoma cell lines. | Int J Clin Exp Pathol | 2014 | https://conductscience.org/library/papers/24817947 | PubMed |
| 22621925 | Complex cisplatin-double strand break (DSB) lesions directly impair cellular non-homologous end-joining (NHEJ) independent of downstream damage response (DDR) pathways. | J Biol Chem | 2012 | https://conductscience.org/library/papers/22621925 | PubMed |
| 17245338 | Phase II trial of docetaxel, cisplatin and fluorouracil followed by carboplatin and radiotherapy in locally advanced oesophageal cancer. | Br J Cancer | 2007 | https://conductscience.org/library/papers/17245338 | PubMed |
| 17084534 | Molecular mechanisms of resistance and toxicity associated with platinating agents. | Cancer Treat Rev | 2007 | https://conductscience.org/library/papers/17084534 | PubMed |
| 16369746 | Phase I study of cisplatin and irinotecan combined with concurrent hyperfractionated accelerated thoracic radiotherapy for locally advanced non-small cell lung carcinoma. | Int J Clin Oncol | 2005 | https://conductscience.org/library/papers/16369746 | PubMed |
| 15886299 | Cisplatin sensitizes cancer cells to ionizing radiation via inhibition of nonhomologous end joining. | Mol Cancer Res | 2005 | https://conductscience.org/library/papers/15886299 | PubMed |
| 12715170 | Expression of apoptosis-related proteins and morphological changes in a rat tumor model of human small cell lung cancer prior to and after treatment with radiotherapy, carboplatin, or combined treatment. | Virchows Arch | 2003 | https://conductscience.org/library/papers/12715170 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8519652
GET https://conductscience.org/api/papers/v1/8519652/references?page=2